Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients-Reference-Cited by-同舟云学术

Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients

Published:2015-06-04 Issue:9 Volume:17 Page:727-736
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Wang Y.,Li R. Q.,Ai Y. Q.,Zhang J.,Zhao P. Z.,Li Y. F.,He W. J.,Xia Y. X.,Li W. H.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-015-1300-4.pdf

Reference28 articles.

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer Statistics. Ca Cancer J Clin. 2014;64:9–29.

2. National health and family planning commission of the People’s Republic of China. China Health Statistics Annual, 2013. http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html .

3. Baas P, Bolderbos JSA, Heuvel MV. Chemoradiation therapy in non-small cell lung cancer. Curr Opin Oncol. 2011;23(2):140–9.

4. Favaretto AG, Pasello G, Magro C. Second and third line treatment in advanced non-small cell lung cancer. Discov Med. 2009;8:204–9.

5. Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004;22(9):1589–97.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary versus acquired epidermal growth factor receptor Thr790Met mutant non-small cell lung cancer: clinical features and prognoses;Clinical and Translational Oncology;2024-01-08

2. Correlation of EGFR mutation subtypes and survival in surgically treated brain metastasis from non-small-cell lung cancer;Asian Journal of Surgery;2023-01

3. Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling;Expert Review of Molecular Diagnostics;2021-12-22

4. Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy;MedComm;2021-12

5. The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma;International Journal of Environmental Research and Public Health;2021-03-11